603127 昭衍新药
2026/06 - 中期
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资0--0019,52922,598
投资性房地产0--0000
固定资产741,082-3.34%766,679696,786583,319590,214
在建工程292,0844.16%280,424368,927342,008277,735
无形资产274,756-3.61%285,054298,514292,380299,536
商誉52,995-3.10%54,690138,037136,007133,739
其他非流动资产2,962,572-2.32%3,032,8252,862,6911,531,9503,111,988
4,323,488-2.18%4,419,6734,364,9552,905,1924,435,810

流动资产
货币资金823,935-9.64%911,854965,2032,862,9122,916,848
应收账款168,104-7.19%181,128181,168206,014199,437
存货1,862,24531.86%1,412,2511,478,5471,863,0822,194,606
其他流动资产3,648,26632.33%2,757,0022,406,2802,189,959617,516
6,502,55123.57%5,262,2365,031,1987,121,9675,928,406

流动负债
短期借款0--0000
应付票据0--0000
应付帐款51,554-30.29%73,95850,22243,323127,309
其他流动负债1,553,81742.99%1,086,6291,060,3461,424,0421,716,953
1,605,37138.32%1,160,5881,110,5691,467,3651,844,262
流动资产净值4,897,18019.40%4,101,6483,920,6295,654,6024,084,144
资产总额减流动负债9,220,6688.21%8,521,3218,285,5848,559,7958,519,953

非流动负债
长期借款0--0003,281
应付债券0--0000
其他非流动负债245,32225.18%195,970206,396278,754325,807
245,32225.18%195,970206,396278,754329,087

总权益
    实收股本749,348-0.02%749,477749,477749,889535,679
    储备项目8,225,6258.58%7,575,5037,329,3417,529,4277,648,023
股东权益8,974,9747.81%8,324,9808,078,8198,279,3168,183,701
非控股权益3730.54%3713701,7257,165